Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @immusoft
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @immusoft
-
Immusoft to present at WORLDSymposium 2020https://www.businesswire.com/news/home/20200205005167/en/Immusoft-Present-WORLDSymposium%E2%84%A2-2020/?feedref=JjAwJuNHiystnCoBq_hl-W8j9Oi60kFTomUxRDB8jhBsNpnJw7dvSfTyni2BOVIOrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3nDlC87j5HoE75BMeA8LaVacVjEfZIyqgxRRsuxHCTK2w%3D%3D&utm_source=dlvr.it&utm_medium=twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immusoft's Chief Development Officer, Dr. Scott McIvor, to present at
#ICLE2019 to discuss Sleeping Beauty-Engineered B lymphocytes on the ISP Platform 9/14/2019 https://www.businesswire.com/news/home/20190910005440/en/Immusoft-Present-International-Conference-Lymphocyte-Engineering-2019 …pic.twitter.com/5Fv7kufHVg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@immusoft Announces appointment of Dr. Robert Hayes as CSO https://www.immusoft.com/2019/07/17/immusoft-announces-the-appointment-of-robert-hayes-ph-d-as-chief-scientific-officer/ …pic.twitter.com/DNT8TGs3hS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pleased to announce today that Immusoft has received Rare Pediatric Disease Designation for treatment of MPS I.https://www.businesswire.com/news/home/20181017005241/en/Immusoft-Receives-Rare-Pediatric-Disease-Designation-Treatment …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited to announce receipt of $3.5 million SBIR grant. It will help us expand our work in MPS I and further explore modalities for delivering proteins across the blood-brain barrier. https://www.businesswire.com/news/home/20180905005295/en/Immusoft-Receives-3.5-Million-Grant-Expand-Cell …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're thrilled to announce that internationally known immunologist, Jason Fontenot, Ph.D., has joined our leadership team as Chief Scientific Officer. https://www.businesswire.com/news/home/20180710005320/en/Jason-Fontenot-Ph.D.-Joins-Immusoft-Chief-Scientific …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
It's International MPS Awareness Day! Wishing all the brave MPS patients and their loved ones the best. It's a privilege to pursue our work in the hope of treating and improving the lives of children with MPS I.
#mpsawareness2018Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pleased to have been granted Orphan Drug Designation to treat MPS I, the first indication in our pipeline. https://www.businesswire.com/news/home/20180502005492/en/Immusoft-Granted-Orphan-Drug-Designation-Treatment-Rare …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Proud to be a winner of the Most Promising Company Award from the Precision Medicine World Conference. Thanks
@PMWCintl for the honor.#PMWC18 https://www.businesswire.com/news/home/20180129005843/en/Immusoft-Recognized-%E2%80%9CMost-Promising-Company-Award%E2%80%9D-Silicon …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited to announce closing the first part of Series B and Sean Ainsworth coming on board as CEO.https://www.businesswire.com/news/home/20180105005213/en/Immusoft-Closes-Part-Series-Financing-New-CEO …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our ideas and process are covered in the May issue of
@seattlebusiness -- Patient, Heal Thyself:http://www.seattlebusinessmag.com/bright-idea-patient-heal-thyself …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Immusoft Corporation proslijedio/la je Tweet
In our latest Q&A, Matthew Scholz discusses how DGI's technology expands & enhances
@immusoft's platform: http://goo.gl/3inLZR#GenomicsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited to announce Discovery Genomics acquisition, bringing us great people and transposon system license.http://www.businesswire.com/news/home/20160308006055/en …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.